tiprankstipranks
Ionis Pharmaceuticals Inc. (IONS)
NASDAQ:IONS
US Market
IONS
Ionis Pharmaceuticals
RESEARCH TOOLSreports
Want to see IONS full AI Analyst Report?

Ionis Pharmaceuticals (IONS) Stock News & Sentiment

1,533 Followers
Ionis: Bepirovirsen Data Reinforce Underappreciated Partnered Pipeline; Buy Rating and $110 Price Target Reiterated
Premium
Ratings
Ionis: Bepirovirsen Data Reinforce Underappreciated Partnered Pipeline; Buy Rating and $110 Price Target Reiterated
5h ago
IONS
Ionis Gains on Positive Phase 3 Hepatitis B Data
Premium
Company Announcements
Ionis Gains on Positive Phase 3 Hepatitis B Data
1d ago
8K
IONS
Ionis Pharmaceuticals: Advancing Pipeline, HBV Phase III Success, and Robust Catalyst Flow Underpin Buy Rating
Premium
Ratings
Ionis Pharmaceuticals: Advancing Pipeline, HBV Phase III Success, and Robust Catalyst Flow Underpin Buy Rating
1d ago
IONS
Ionis Buy Rating Reiterated as Analyst Cites Tryngolza’s Competitive Moat and Confirms Unchanged $125 Price Target
Premium
Ratings
Ionis Buy Rating Reiterated as Analyst Cites Tryngolza’s Competitive Moat and Confirms Unchanged $125 Price Target
2d ago
IONS
Citi Names 2 Biotech Stocks ‘Top Picks’ for 2026
Premium
Market News
Citi Names 2 Biotech Stocks ‘Top Picks’ for 2026
5d ago
CYTK
IONS
Ionis Pharmaceuticals: Buy Rating Reaffirmed as Alzheimer’s Program Advances and Price Target Raised to $111 from $100
Premium
Ratings
Ionis Pharmaceuticals: Buy Rating Reaffirmed as Alzheimer’s Program Advances and Price Target Raised to $111 from $100
14d ago
IONS
Pelacarsen Phase 3 HORIZON Trial Seen as Key Catalyst Supporting Ionis Buy Rating and Unchanged $105 Price Target
Premium
Ratings
Pelacarsen Phase 3 HORIZON Trial Seen as Key Catalyst Supporting Ionis Buy Rating and Unchanged $105 Price Target
14d ago
IONS
More IONS News >

IONS News on the Web

Ionis: Bepirovirsen Data Reinforce Underappreciated Partnered Pipeline; Buy Rating and $110 Price Target Reiterated
TipRanks News
Bullish
Analysts Have Conflicting Sentiments on These Healthcare Companies: Erasca (ERAS), Ionis Pharmaceuticals (IONS) and Capricor Therapeutics (CAPR)
TipRanks News
Bullish
Ionis Gains on Positive Phase 3 Hepatitis B Data
TipRanks News
Neutral
Ionis Pharmaceuticals: Advancing Pipeline, HBV Phase III Success, and Robust Catalyst Flow Underpin Buy Rating
TipRanks News
Bullish
Analysts Are Bullish on Top Healthcare Stocks: ClearPoint Neuro (CLPT), Ionis Pharmaceuticals (IONS)
TipRanks News
Bullish
Ionis partner GSK reports B-Well 1, B-Well 2 trials meet primary endpoint
TipRanks News
Bullish
Ionis Buy Rating Reiterated as Analyst Cites Tryngolza’s Competitive Moat and Confirms Unchanged $125 Price Target
TipRanks News
Bullish
Ionis Pharmaceuticals Eyes Big Year With TRYNGOLZA Decision, 5 Phase 3 Readouts
MarketBeat
Bullish

News Score - Last 7 Days

Very Positive
IONS
Sector Average
Media Buzz
This Week7 articles
Weekly Average10.25 articles
News Sentiment
This Week99%
Sector Average79%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IONS’s Media Buzz Sentiment?
7 articles about IONS were published this week. In an average week, 10.25 articles are published.
    What is IONS’s weekly average amount of articles?
    In an average week, 10.25 articles about IONS are published.
      What is IONS’s News Sentiment?
      99% of articles about IONS were positive this week, compared to its sector average of 79%.
        Healthcare Stocks that are Trending in the News
        AKTXAkari Therapeutics
        IMMXImmix Biopharma
        SYSo-Young International
        ADOAnteoTech Ltd
        FSPKFFisher & Paykel Healthcare Corporation Limited
        Showing the stocks with the most bullish news sentiment over the past week